购物车
- 全部删除
- 您的购物车当前为空
Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to most currently used antiviral medications.
Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to most currently used antiviral medications.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 9,620 | 1-2周 | |
50 mg | ¥ 12,500 | 1-2周 | |
100 mg | ¥ 17,500 | 1-2周 |
产品描述 | Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to most currently used antiviral medications. |
靶点活性 | GT1b:0.01±<0.01 nM (Ki), GT1a:0.01±0.01 nM (Ki), GT2a:0.08±0.02 nM (Ki), GT3a:0.90±0.2 nM (Ki), GT2b:0.15±0.06 nM (Ki) |
别名 | MK-5172, MK5172, MK 5172, Grazoprevir |
分子量 | 784.92 |
分子式 | C38H52N6O10S |
CAS No. | 1350462-55-3 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度信息 | DMSO: Soluble H2O: Insoluble |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容